Newly Approved Oral Medication Slows Rheumatoid Arthritis Joint Damage
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis patients who did not respond to methotrexate .Full Story
Since: Jan 13
#1 Jan 25, 2013
This could be great information for arthritis people.Thanks for information.
#2 Apr 1, 2013
Wow this is amazing if it really slows down the effects of arthritis. I have read somewhere at depuypinnaclelawsuit. com that there may be some preoblems with hip replacements so this is a new alternative.
Add your comments below
|Pizza chain sued over healthcare for gay couples (Aug '14)||5 min||lides||32|
|Growing e-cigarette trend raises safety concerns (Jul '13)||41 min||Howdy friend||138|
|Wakefield is not a fraud - His study linking MM...||48 min||friend||42|
|Vaccination opponents protest bill from Allento...||56 min||Justice||2|
|Erectile dysfunction raises risk of hospitaliza... (Feb '13)||1 hr||joshjonhson||15|
|Study: Impotence Drugs Don't Cause Vision Damage (Apr '09)||1 hr||joshjonhson||19|
|Sex pills can cause blue vision and vision loss (Sep '09)||2 hr||joshjonhson||48|
|Pregnancy Symptoms - 12 Very Early Symptoms of ... (Jun '07)||14 hr||Sally||6,178|
Find what you want!
Search Health Forum Now
Copyright © 2015 Topix LLC